Legal Representation
Attorney
Gene K. Park
USPTO Deadlines
Next Deadline
1 days remaining
Non-Final Action Mailed
Due Date
November 07, 2025
Extension Available
Until February 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 21, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 21, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 21, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 21, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 21, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 7, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 7, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 7, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 30, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 30, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 29, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 24, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Feb 21, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Detailed Classifications
Class 005
Drug delivery agents in the form of liquid for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; enzymes for medical purposes, namely, for facilitating delivery of fluids or pharmaceuticals; drug delivery agents consisting of pharmaceuticals containing enzymes that facilitate delivery of fluids and a wide range of pharmaceuticals; pharmaceutical preparations for use in the treatment and prevention of metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, dermatological conditions and disorders, and for the treatment of cancer and in hydration; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in aesthetic skin treatments; Hyaluronic acid for pharmaceutical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures; enzymes for medical purposes, namely, recombinant human hyaluronidase formulation for use in in-vitro fertilization procedures
Class 035
Administration of a discount program enabling patients to obtain discounts on prescription drugs through use of a discount card provided by a copay discount program; business administration of a program enabling patients to obtain discounts on prescription drugs through a cash-pay program for uninsured and underinsured patients
Class 036
Insurance benefits verification and prior authorization assistance in the health industry; copay assistance programs, namely, providing financial assistance to uninsured and underinsured patients for prescription medications
Class 042
Scientific research and development services for the integration of technologies, therapies, and other systems for pharmaceuticals and drug delivery systems
Class 044
Providing medical information in the field of subcutaneous fluid administration; providing medical information in the field of subcutaneous delivery of a wide range of pharmaceuticals
Classification
International Classes
005
035
036
042
044